tnbc
No description yet: the sentence for this tag has not been written. 3 records carry it: 3 people.
3 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Elizabeth A. Mittendorf Director, Breast Immuno-Oncology Program, Dana-Farber Brigham Cancer Center · Dana-Farber Brigham Cancer Center Surgeon-scientist who led IMpassion031 and studies of surgery de-escalation after neoadjuvant immunotherapy. | Triple-negative breast cancer | none | surgery, immunotherapy | ||
Lajos Pusztai Professor of Medicine and Co-Leader, Genetics, Genomics and Epigenetics Program, Yale Cancer Center · Yale Cancer Center / Smilow Cancer Hospital Translational breast oncologist who co-leads the I-SPY2 platform trial and helped show immunotherapy works in early TNBC. | Triple-negative breast cancer | none | platform-trial, biomarkers | ||
Peter Schmid Professor of Cancer Medicine and Lead, Centre for Experimental Cancer Medicine, Barts Cancer Institute · Barts Cancer Institute / Barts Health NHS Trust Led KEYNOTE-522 and IMpassion130, the trials that brought immunotherapy into triple-negative breast cancer. | Triple-negative breast cancer | none | immunotherapy, trialist |